Intranasal mechanical stimulation

From MEpedia, a crowd-sourced encyclopedia of ME and CFS science and history
The printable version is no longer supported and may have rendering errors. Please update your browser bookmarks and please use the default browser print function instead.

Intranasal mechanical stimulation or INMEST is a method of stimulating the vagus nerve from inside the nose.[1]

Theory[edit | edit source]

Evidence in ME/CFS[edit | edit source]

A small placebo-controlled randomized clinical trial by Rodriguez et al. (2020) of moderate and severe patients with ME/CFS found that a 30% reduction in symptoms was achieved after 8 weeks of INMEST treatment; however the fatigue level of patients did not change.[1] The trial used patients who fulfilled the Canadian Consensus Criteria.[1] Dr Jan-Erik Juto, one of the authors of Rodriguez et al. (2020), is a co-founder and stakeholder of Albilion Medical Systems AB, who developed INMEST.

Clinicians[edit | edit source]

Risks and safety[edit | edit source]

Costs and availability[edit | edit source]

See also[edit | edit source]

Learn more[edit | edit source]

References[edit | edit source]

  1. 1.0 1.1 1.2 Rodriguez, Lucie ST; Pou, Christian; Tadepally, Lakshmikanth; Zhang, Jingdian; Mugabo, Constantin Habimana; Wang, Jun; Mikes, Jaromir; Olin, Axel; Chen, Yang; Mikes, Jaromir; Olin, Axel; Chen, Yang; Rorbach, Joanna; Juto, Jan-Erik (February 21, 2020). "Achieving symptom relief in patients with Myalgic encephalomyelitis by targeting the neuro-immune interface and inducing disease tolerance" (PDF). bioRxiv: 2020.02.20.958249. doi:10.1101/2020.02.20.958249. Retrieved February 25, 2020.